Anna M. Dahlin

2.4k total citations
36 papers, 1.8k citations indexed

About

Anna M. Dahlin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Anna M. Dahlin has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Anna M. Dahlin's work include Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (8 papers) and Genetic factors in colorectal cancer (4 papers). Anna M. Dahlin is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (8 papers) and Genetic factors in colorectal cancer (4 papers). Anna M. Dahlin collaborates with scholars based in Sweden, United States and Denmark. Anna M. Dahlin's co-authors include Richard Palmqvist, Åke Öberg, Martin Rutegård, Sofia Edin, Maria L. Wikberg, Bethany Van Guelpen, Maria L. Henriksson, Per‐Arne Oldenborg, Roger Stenling and Vincy Eklöf and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Anna M. Dahlin

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna M. Dahlin Sweden 15 917 494 457 383 337 36 1.8k
Kyueng‐Whan Min South Korea 22 553 0.6× 597 1.2× 387 0.8× 124 0.3× 304 0.9× 136 1.6k
Mariano Severgnini United States 21 1.0k 1.1× 599 1.2× 525 1.1× 738 1.9× 312 0.9× 53 2.1k
Paolo Bianchi Italy 30 1.5k 1.6× 752 1.5× 409 0.9× 725 1.9× 405 1.2× 76 3.1k
Yoshito Terai Japan 29 697 0.8× 1.1k 2.3× 187 0.4× 378 1.0× 451 1.3× 136 2.7k
Raphaël Maréchal Belgium 22 1.5k 1.6× 497 1.0× 403 0.9× 301 0.8× 479 1.4× 63 2.3k
Stéphane Vignot France 16 686 0.7× 630 1.3× 391 0.9× 117 0.3× 469 1.4× 91 1.7k
Min Yuen Teo United States 16 925 1.0× 602 1.2× 672 1.5× 211 0.6× 394 1.2× 91 1.9k
Kitty Pavlakis Greece 23 510 0.6× 576 1.2× 299 0.7× 92 0.2× 346 1.0× 80 1.6k
Zachary S. Buchwald United States 23 818 0.9× 496 1.0× 477 1.0× 427 1.1× 252 0.7× 62 1.7k

Countries citing papers authored by Anna M. Dahlin

Since Specialization
Citations

This map shows the geographic impact of Anna M. Dahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Dahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Dahlin more than expected).

Fields of papers citing papers by Anna M. Dahlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M. Dahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Dahlin. The network helps show where Anna M. Dahlin may publish in the future.

Co-authorship network of co-authors of Anna M. Dahlin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M. Dahlin. A scholar is included among the top collaborators of Anna M. Dahlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M. Dahlin. Anna M. Dahlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Söderlund, Maria, et al.. (2025). The impact of socioeconomic status on glioma survival: a retrospective analysis. Cancer Causes & Control. 36(6). 577–586. 1 indexed citations
2.
Li, Shaobo, Christian M. Hagen, Ulrik Kristoffer Stoltze, et al.. (2023). Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus. Neuro-Oncology. 25(9). 1709–1720. 8 indexed citations
4.
Andersson, Ulrika, Sofie Degerman, Anna M. Dahlin, et al.. (2018). The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking. Cancer Causes & Control. 30(2). 177–185. 7 indexed citations
5.
Wibom, Carl, et al.. (2016). Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Journal of Neuro-Oncology. 127(3). 483–492. 28 indexed citations
6.
Andersson, Ulrika, Anna M. Dahlin, Hilde Langseth, et al.. (2016). Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumor Biology. 37(8). 11065–11072. 7 indexed citations
7.
Wibom, Carl, Anna M. Dahlin, Hilde Langseth, et al.. (2015). Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 24(5). 810–816. 15 indexed citations
8.
Dahlin, Anna M., Mads V. Hollegaard, Carl Wibom, et al.. (2015). CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma. Journal of Neuro-Oncology. 125(1). 75–78. 14 indexed citations
9.
Vickers, Andrew J., David Ulmert, Daniel D. Sjoberg, et al.. (2013). Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ. 346(apr15 5). f2023–f2023. 173 indexed citations
10.
Eklöf, Vincy, Maria L. Wikberg, Sofia Edin, et al.. (2013). The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer. British Journal of Cancer. 108(10). 2153–2163. 134 indexed citations
11.
Wikberg, Maria L., Sofia Edin, Ida Lundberg, et al.. (2013). High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumor Biology. 34(2). 1013–1020. 139 indexed citations
12.
Edin, Sofia, Maria L. Wikberg, Anna M. Dahlin, et al.. (2012). The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer. PLoS ONE. 7(10). e47045–e47045. 387 indexed citations
13.
Henriksson, Maria L., Sofia Edin, Anna M. Dahlin, et al.. (2011). Colorectal Cancer Cells Activate Adjacent Fibroblasts Resulting in FGF1/FGFR3 Signaling and Increased Invasion. American Journal Of Pathology. 178(3). 1387–1394. 116 indexed citations
14.
Palmqvist, Richard, Maria L. Henriksson, Anna M. Dahlin, et al.. (2011). High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer. PLoS ONE. 6(8). e23003–e23003. 61 indexed citations
15.
Palmqvist, Richard, Anna M. Dahlin, Bethany Van Guelpen, et al.. (2011). High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis. International Journal of Cancer. 131(4). 779–788. 36 indexed citations
16.
Dahlin, Anna M., Richard Palmqvist, Maria L. Henriksson, et al.. (2010). The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status. Clinical Cancer Research. 16(6). 1845–1855. 141 indexed citations
17.
Vickers, Andrew J., A. Cronin, Thomas Björk, et al.. (2010). Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. PubMed. 341(sep14 1). c4521–c4521. 151 indexed citations
18.
Guelpen, Bethany Van, Anna M. Dahlin, Johan Hultdin, et al.. (2009). One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case–referent study. Cancer Causes & Control. 21(4). 557–566. 33 indexed citations
19.
Dahlin, Anna M., Bethany Van Guelpen, Johan Hultdin, et al.. (2007). Plasma vitamin B12 concentrations and the risk of colorectal cancer: A nested case‐referent study. International Journal of Cancer. 122(9). 2057–2061. 31 indexed citations
20.
Dahlin, Anna M., et al.. (2005). Press coverage and sales of Xenical in Sweden, 1998–2000. European Journal of Clinical Pharmacology. 61(4). 285–289. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026